###begin article-title 0
Parkin occurs in a stable, non-covalent, approximately110-kDa complex in brain
###end article-title 0
###begin p 1
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 1
###begin p 2
###xml 122 130 122 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 934 940 922 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 1095 1102 1083 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 428 433 <span type="species:ncbi:10090">mouse</span>
Mutations in the gene for parkin, a 52-kDa E3 ubiquitin ligase, are a major cause of hereditary Parkinson's disease (PD). In vitro studies have identified a large number of parkin-interacting proteins. Whether parkin exists as a monomer or as part of a stable protein complex in vivo is uncertain. Here we demonstrate that endogenous parkin occurs in a stable, non-covalent, approximately110-kDa complex in native extracts from mouse brain, heart and skeletal muscle, while monomeric parkin is undetectable. Partial denaturation experiments indicate that this complex is at least a tetramer. Reported parkin-binding partners do not show detectable association with the parkin complex on native gels. Upon overexpression in COS1, SH-SY5Y or CHO cells, parkin accumulates predominantly as a monomer, suggesting that the interactors required for complex formation are available in limiting amounts in these cells. Importantly, PD-linked parkin mutations significantly impair parkin complex formation. These data demonstrate that parkin oligomerizes into a stable, non-covalent, heteromeric complex in vivo, and suggest that parkin may have as yet unidentified stable binding partners.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parkin</italic>
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 163 182 163 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Kitada <italic>et al.</italic>, 1998</xref>
###xml 192 198 192 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 184 204 184 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">L&#252;cking <italic>et al.</italic>, 2000</xref>
###xml 337 343 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 332 349 332 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Imai <italic>et al.</italic>, 2000</xref>
###xml 359 365 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 351 371 351 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Shimura <italic>et al.</italic>, 2000</xref>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 373 391 373 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Zhang <italic>et al.</italic>, 2000</xref>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 576 582 576 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 571 588 571 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Henn <italic>et al.</italic>, 2005</xref>
###xml 597 603 597 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 590 609 590 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Sriram <italic>et al.</italic>, 2005</xref>
###xml 629 635 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 906 924 906 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
Parkin mutations are among the most common causes of familial Parkinson's disease (PD), accounting for approximately 50% of early onset autosomal recessive cases (Kitada et al., 1998; Lucking et al., 2000). Parkin is a cytosolic, 52-kDa E3 ubiquitin ligase responsible for targeting specific substrates for proteasomal degradation (Imai et al., 2000; Shimura et al., 2000; Zhang et al., 2000). A variety of PD-linked parkin mutations have been shown to induce a loss of parkin function through direct catalytic impairment or by decreasing parkin solubility or stability (Henn et al., 2005; Sriram et al., 2005). Thus, pathogenic parkin mutations could cause neurodegeneration through a toxic accumulation of one or more parkin substrates. However, other PD-linked parkin mutations have no discernible impact on the intrinsic ubiquitin ligase activity, solubility or other biochemical properties of parkin (Hampe et al., 2006), and the pathogenic mechanism of these mutations remains unknown.
###end p 4
###begin p 5
###xml 132 138 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 126 144 126 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Zhang <italic>et al.</italic>, 2000</xref>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 160 178 160 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Chung <italic>et al.</italic>, 2001</xref>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 242 259 242 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">Imai <italic>et al.</italic>, 2001</xref>
###xml 302 308 298 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 294 314 290 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Shimura <italic>et al.</italic>, 2001</xref>
###xml 341 347 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 337 353 326 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Ren <italic>et al.</italic>, 2003</xref>
###xml 376 382 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 366 388 355 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Staropoli <italic>et al.</italic>, 2003</xref>
###xml 455 461 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 449 467 438 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Corti <italic>et al.</italic>, 2003</xref>
###xml 576 582 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 573 588 562 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Um <italic>et al.</italic>, 2006</xref>
###xml 610 616 599 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 604 622 593 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">Huynh <italic>et al.</italic>, 2007</xref>
###xml 718 724 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 714 730 703 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">Lim <italic>et al.</italic>, 2005</xref>
###xml 827 833 816 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 820 839 809 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Fallon <italic>et al.</italic>, 2006</xref>
###xml 943 949 920 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 938 955 915 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Henn <italic>et al.</italic>, 2007</xref>
A large number of putative parkin substrates have been reported, including cell division control-related protein 1 (CDCrel-1; Zhang et al., 2000), synphilin-1 (Chung et al., 2001), parkin-associated endothelin receptor-like receptor (Pael-R; Imai et al., 2001), O-glycosylated alpha-synuclein (Shimura et al., 2001), alpha/beta-tubulin (Ren et al., 2003), cyclin E (Staropoli et al., 2003), the p38 subunit of the aminoacyl-tRNA synthetase complex (Corti et al., 2003), the nuclear membrane-associated protein Ras-related nuclear small G-protein-binding protein 2 (RanBP2; Um et al., 2006) and ataxin-2 (Huynh et al., 2007). Importantly, parkin may also ubiquitinate substrates in proteasome-independent pathways (Lim et al., 2005), as recently shown for epidermal-growth-factor receptor pathway substrate clone (Eps15; Fallon et al., 2006), tumour necrosis factor receptor-associated factor 2 (TRAF2) and IkappaB kinase gamma (IKKgamma; Henn et al., 2007).
###end p 5
###begin p 6
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 299 316 299 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Imai <italic>et al.</italic>, 2002</xref>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 417 435 417 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Kalia <italic>et al.</italic>, 2004</xref>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 467 484 467 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Imai <italic>et al.</italic>, 2002</xref>
###xml 505 511 503 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 500 517 498 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Sato <italic>et al.</italic>, 2006</xref>
###xml 671 677 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 661 683 659 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Staropoli <italic>et al.</italic>, 2003</xref>
###xml 904 910 902 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 897 916 895 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Fallon <italic>et al.</italic>, 2002</xref>
###xml 1001 1007 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 996 1013 987 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Yang <italic>et al.</italic>, 2005</xref>
###xml 1106 1112 1097 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1101 1118 1092 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Imai <italic>et al.</italic>, 2000</xref>
###xml 1128 1134 1119 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1120 1140 1111 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Shimura <italic>et al.</italic>, 2001</xref>
###xml 1280 1286 1271 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1273 1292 1264 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Sakata <italic>et al.</italic>, 2003</xref>
###xml 1312 1318 1303 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1304 1324 1295 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Dachsel <italic>et al.</italic>, 2005</xref>
###xml 1396 1402 1387 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1389 1408 1380 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Baulac <italic>et al.</italic>, 2004</xref>
###xml 1457 1463 1448 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1451 1469 1442 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Smith <italic>et al.</italic>, 2005</xref>
###xml 1078 1083 <span type="species:ncbi:9606">human</span>
In addition to binding transiently to substrates, parkin may also interact more stably with non-substrate-binding partners. For example, binding of parkin to C-terminus of heat shock protein 70 (Hsp70)-interacting protein (CHIP) has been reported to enhance the ubiquitin ligase activity of parkin (Imai et al., 2002). Conversely, parkin activity is inhibited by interaction with bcl-2-associated athanogene 5 (BAG5; Kalia et al., 2004) or with the chaperones Hsp70 (Imai et al., 2002) or 14-3-3eta (Sato et al., 2006). According to a different study parkin functions in a multiprotein ubiquitin ligase complex including the F-box protein hSel-10 and cullin-1 (Staropoli et al., 2003). In this complex hSel-10, rather than parkin itself, would be responsible for substrate recognition. Association with calcium/calmodulin-dependent serine protein kinase (CASK) may localize parkin to the synapse (Fallon et al., 2002), while interaction with alpha/beta tubulin may anchor parkin to microtubules (Yang et al., 2005). Parkin may associate with the E2 enzyme ubiquitin-conjugating human enzyme 7 (UbcH7; Imai et al., 2000; Shimura et al., 2001), or may be attached to the proteasome through interactions with the proteasomal subunits regulatory particle non-ATPase 10 (Rpn10; Sakata et al., 2003) or XAPC7 (Dachsel et al., 2005). Finally, parkin has also been reported to interact with DJ-1 (Baulac et al., 2004) and leucine-rich repeat kinase 2 (LRRK2; Smith et al., 2005), two other proteins linked to familial PD.
###end p 6
###begin p 7
###xml 65 73 65 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 90 95 <span type="species:ncbi:4932">yeast</span>
Many of the reported parkin interactions were identified through in vitro assays, such as yeast-two-hybrid studies, and the in vivo significance of these interactions is uncertain. Whether parkin exists as a monomer or as part of a stable protein complex in the brain remains unknown. Here we address this question using velocity gradient centrifugation, blue native-polyacrylamide gel electrophoresis (BN-PAGE) and gel filtration chromatography.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
Antibodies
###end title 9
###begin p 10
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 131 150 131 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Pawlyk <italic>et al.</italic>, 2003</xref>
###xml 11 17 <span type="species:ncbi:9986">rabbit</span>
###xml 220 226 <span type="species:ncbi:9986">rabbit</span>
###xml 241 247 <span type="species:ncbi:9986">rabbit</span>
###xml 275 281 <span type="species:ncbi:9986">rabbit</span>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
###xml 462 468 <span type="species:ncbi:9986">rabbit</span>
###xml 511 515 <span type="species:ncbi:9925">goat</span>
###xml 527 533 <span type="species:ncbi:9986">rabbit</span>
###xml 561 567 <span type="species:ncbi:9986">rabbit</span>
###xml 622 628 <span type="species:ncbi:9986">rabbit</span>
###xml 669 674 <span type="species:ncbi:10090">mouse</span>
###xml 710 716 <span type="species:ncbi:9986">rabbit</span>
###xml 762 766 <span type="species:ncbi:9925">goat</span>
###xml 801 807 <span type="species:ncbi:9986">rabbit</span>
###xml 839 845 <span type="species:ncbi:9986">rabbit</span>
###xml 887 893 <span type="species:ncbi:9986">rabbit</span>
###xml 923 928 <span type="species:ncbi:10090">mouse</span>
###xml 959 965 <span type="species:ncbi:9986">rabbit</span>
###xml 1048 1054 <span type="species:ncbi:9986">rabbit</span>
Polyclonal rabbit anti-parkin antibody (CS2132) was from Cell Signalling Technology; monoclonal parkin antibodies PRK8 and PRK109 (Pawlyk et al., 2003) were a kind gift from Dr Virginia Lee (University of Pennsylvania); rabbit anti-CUL1 and rabbit anti-CASK were from Zymed; rabbit anti-hSel-10 (anti-hCdc4, 69-kDa isoform) was from Gentaur Molecular Products; mouse antibodies against CDCrel-1, UbcH7 and alpha-synuclein were from BD Transduction Laboratories; rabbit anti-Hsp70 was from Stressgen; polyclonal goat anti-DJ-1, rabbit anti-IKKgamma (FL-419) and rabbit anti-TRAF2 (C-20) were from Santa Cruz Biotechnology; rabbit anti-BAG5 was from Exalpha Biologicals; mouse anti-alpha-tubulin was from Sigma; rabbit anti-alpha-tubulin and anti-beta-tubulin and goat anti-synphilin-1 were from Abcam; rabbit anti-CHIP was from Calbiochem; rabbit anti-Rpn10 (anti-PSMD4) was from Abgent; rabbit anti-14-3-3eta was from IBL; mouse anti-XAPC7 was from Biotrend; rabbit anti-p38 was a kind gift from Dr S. Kim (Seoul National University); and purified rabbit IgG was from Chemicon.
###end p 10
###begin title 11
Tissue extraction, glycerol gradient centrifugation and BN-PAGE
###end title 11
###begin p 12
###xml 247 253 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 241 259 235 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Itier <italic>et al.</italic>, 2003</xref>
###xml 442 443 436 437 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 668 674 658 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 659 680 649 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">Sch&#228;gger <italic>et al.</italic>, 1994</xref>
###xml 695 701 685 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 682 708 672 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Vandenberghe <italic>et al.</italic>, 2005a</xref>
###xml 747 748 737 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 747 748 737 738 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 804 805 794 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 804 805 794 795 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 806 813 796 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 886 887 876 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 886 887 876 877 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 896 897 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 896 897 886 887 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 967 974 957 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1B</xref>
###xml 1016 1017 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1016 1017 1006 1007 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 1049 1050 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1049 1050 1039 1040 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 1184 1185 1174 1175 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1332 1333 1322 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1332 1333 1322 1323 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 1453 1454 1443 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1453 1454 1443 1444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 1971 1972 1949 1950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1971 1972 1949 1950 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 1972 1974 1950 1952 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">av</sub>
###xml 1989 1995 1967 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1976 2002 1954 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Vandenberghe <italic>et al.</italic>, 2005a</xref>
###xml 2218 2224 2188 2194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2205 2231 2175 2201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Vandenberghe <italic>et al.</italic>, 2005a</xref>
###xml 2487 2493 2457 2463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2482 2499 2452 2469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">Yang <italic>et al.</italic>, 2002</xref>
###xml 2514 2520 2484 2490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2501 2527 2471 2497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Vandenberghe <italic>et al.</italic>, 2005a</xref>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
All the steps of tissue preparation, glycerol gradient centrifugation and BN-PAGE were performed at 4 degreesC. Brain stem and diencephalon, heart or skeletal muscle were dissected from 2- to 4-month-old wild-type (C57/Bl6J) or parkin-null (Itier et al., 2003) mice after decapitation. Procedures followed were approved by the ethical committee of the University of Leuven. The tissue was homogenized with a glass pestle in 10 volumes of 20 mm Tris-HCl, pH 7.4, followed by trituration through a 200-microL pipette tip. The homogenization buffer did not contain salts, because salts may lead to precipitation of Coomassie dye and stained proteins on BN gels (Schagger et al., 1994; Vandenberghe et al., 2005a). Homogenates were centrifuged at 200 g for 5 min, followed by an additional 5 min spin at 350 g(Fig. 1A). Control experiments indicated that the pellets obtained after the 200 g and 350 g centrifugation steps did not contain a significant amount of parkin (Fig. 1B). The supernatant obtained after the 350 g spin was centrifuged at 20 000 g for 2 min, leading to separation of pellet (P) and supernatant (S) fractions. P was resuspended in 10 volumes of 1% Triton X-100/20 mm Tris, pH 7.4. Triton X-100 was also added to S to a final concentration of 1%. After incubation for 30 min the samples were centrifuged at 20 000 g for 5 min. To test whether parkin was fully extracted in 1% Triton X-100, the pellets remaining after the final 20 000 g spin were solubilized in 1.5% sodium dodecyl sulphate (SDS) at 100 degreesC for 10 min. However, SDS-PAGE and Western blot with PRK8 did not detect any parkin in this Triton X-100-resistant, SDS-extractable fraction (data not shown). Protein concentrations of the Triton X-100 extracts were determined for P and S with the Bio-Rad Protein assay. Approximately 2 mg of protein extract was layered onto 10-50% glycerol gradients. Gradients were centrifuged in a SW-55 rotor (Beckman) at 4 degreesC for 18 h at 165 000 gav (Vandenberghe et al., 2005a). Twelve fractions of 450 microL were collected manually from the top, and 90 microL of each fraction was loaded on BN gels. BN-PAGE and immunoblotting were performed as previously described in detail (Vandenberghe et al., 2005a), except that 4-20% gradient gels were used in the present study. Immunoreaction was visualized with ECL or ECL Plus (Pierce), and exposure of the membrane to Kodak X-OMAT film. Antibody supershift experiments were performed as previously described (Yang et al., 2002; Vandenberghe et al., 2005a).
###end p 12
###begin p 13
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 282 283 282 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 363 364 363 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 514 515 514 515 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 584 585 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 584 585 584 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 169 174 <span type="species:ncbi:10090">Mouse</span>
Tissue extraction, glycerol gradient centrifugation and blue-native-polyacrylamide gel electrophoresis (BN-PAGE) procedure. (A) Schematic overview of the procedure. (B) Mouse brain stem and diencephalon were homogenized as described in Materials and methods, and centrifuged at 350 g for 5 min. The pellet (Lane 1) and supernatant (Lane 2) obtained after the 350 g spin were compared for parkin content. SDS was added to the supernatant at a final concentration of 2%, and the pellet was resuspended in 2% SDS/20 mm Tris, pH 7.4. After boiling for 10 min and centrifugation at 14 000 g for 5 min, 60 microg of protein extract was loaded in each lane and examined by SDS-PAGE and Western blotting with the monoclonal anti-parkin antibody PRK109. The mobility of a 50-kDa molecular weight marker is shown on the left of the blot.
###end p 13
###begin title 14
Gel filtration chromatography
###end title 14
###begin p 15
###xml 211 212 211 212 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 222 223 222 223 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 481 487 <span type="species:ncbi:9913">bovine</span>
Approximately 1 mg of S fraction, prepared as described above except that Triton X-100 was omitted, was applied to a Superdex 200 HR 16/50 column (Pharmacia). The column was pre-equilibrated and eluted with 50 mm NaCl/25 mm Tris-HCl, pH 7.4. Elution was at a flow rate of 1 mL/min at 4 degreesC. Fractions of 0.5 mL were collected and analysed with dot blot for parkin. Calibration standards, including thyroglobulin (669 kDa), ferritin (440 kDa), lactate dehydrogenase (140 kDa), bovine serum albumin (67 kDa), vitamin D-binding protein (55 kDa) and protein phosphatase 2A phosphatase activator (36 kDa) were separated on the column under the same conditions and detected by UV light detection at 280 nm.
###end p 15
###begin title 16
Cell cultures and transfection
###end title 16
###begin p 17
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 65 91 65 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Vandenberghe <italic>et al.</italic>, 2005b</xref>
###xml 246 247 246 247 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 264 265 264 265 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 279 280 279 280 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 490 491 486 487 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 505 506 501 502 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 769 775 761 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 756 782 748 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Vandenberghe <italic>et al.</italic>, 2005b</xref>
###xml 820 821 812 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1182 1188 1174 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1171 1194 1163 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Winklhofer <italic>et al.</italic>, 2003</xref>
###xml 1483 1489 1475 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1477 1495 1469 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
###xml 2235 2236 2224 2225 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 2344 2345 2327 2328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 2344 2345 2327 2328 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 382 386 <span type="species:ncbi:9913">calf</span>
###xml 608 612 <span type="species:ncbi:9913">calf</span>
###xml 1041 1046 <span type="species:ncbi:9606">Human</span>
COS1 cells were cultured as previously described for COS7 cells (Vandenberghe et al., 2005b). CHO and HEK-293 cells were cultured in a 1 : 1 mix of Dulbecco's modified Eagle medium (DMEM) and F-12 nutrient mixture (Invitrogen), supplemented with l-glutamine (2.5 mm), HEPES (15 mm), non-essential amino acids (1%), penicillin (100 U/mL), streptomycin (100 microg/mL) and 10% foetal calf serum. SH-SY5Y cells were cultured in a 1 : 1 mix of DMEM and F-12 nutrient mixture, supplemented with l-glutamax (4 mm), non-essential amino acids (1%), penicillin (100 U/mL), streptomycin (100 microg/mL) and 15% foetal calf serum. COS1, CHO and HEK-293 cells were transiently transfected using Lipofectamine Plus (Invitrogen), as previously described for COS7 cells (Vandenberghe et al., 2005b). We transfected 80 ng of cDNA per cm2 of COS1, CHO or HEK-293 cell culture, unless otherwise indicated. SH-SY5Y cells were transiently transfected with the Nucleofector system (Amaxa) using the T16 program according to the instructions of the manufacturer. Human wild-type parkin cDNA was kindly provided by Dr K. Winklhofer (Max-Planck-Institute for Biochemistry, Martinsried, Germany; Winklhofer et al., 2003). In experiments comparing wild-type and pathogenic parkin variants, COS1 cells were transfected with cDNAs encoding HA-tagged versions of wild-type, A82E, K161N, K211N, R256C and R275W parkin. The cDNAs for these HA-tagged parkin versions were constructed as previously described (Hampe et al., 2006). Under the transfection conditions used in this study, phase-contrast microscopy immediately before cell harvest revealed no observable toxicity of COS1 cells expressing wild-type or PD-linked parkin versions (not shown). This was confirmed by SDS-PAGE and Western blot experiments showing similar beta-tubulin levels in COS1 cells transfected with the different parkin variants (not shown), thus assuring similar amounts of cellular input material. Two days after COS1, CHO and HEK-293 cell transfection, and 24 h after SH-SY5Y cell transfection, the medium was aspirated and the cells were washed in ice-cold phosphate-buffered saline (PBS). The cells were removed from the plate with a cell scraper, resuspended in 1% Triton X-100/20 mm Tris, and solubilized for 30 min at 4 degreesC. Insoluble material was removed by centrifugation at 20 000 g for 5 min. Total protein concentrations of the Triton X-100 extracts were determined with the Bio-Rad Protein assay, and 500 microg of protein extract was layered onto 10-50% glycerol gradients. Glycerol gradient centrifugation and BN-PAGE was performed in the same way as for the brain extracts. In each of the glycerol gradient and BN-PAGE experiments comparing parkin complex formation between wild-type and pathogenic variants, we also compared the soluble levels of wild-type and mutant parkin versions by parallel SDS-PAGE of 15 microg of the Triton-soluble protein extracts. After Western blotting, the density of scanned signals was measured with UN-SCAN-IT gel 6.1 software (Silk Scientific). For quantitative experiments, film exposure times below the saturation range were used, as determined by multiple exposure times and as confirmed by the UN-SCAN-IT saturation check.
###end p 17
###begin title 18
Production and purification of recombinant parkin
###end title 18
###begin p 19
###xml 44 60 44 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 171 177 171 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 165 183 165 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
###xml 635 636 619 620 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 44 60 <span type="species:ncbi:562">Escherichia coli</span>
###xml 233 239 <span type="species:ncbi:9913">bovine</span>
GST-tagged wild-type parkin was produced in Escherichia coli, batch purified with glutathione-Sepharose, eluted from the beads and dialysed as previously described (Hampe et al., 2006). GST-parkin was quantified by comparison with a bovine serum albumin standard after SDS-PAGE and staining of the gel with Coomassie Blue, aliquoted and stored at -80 degreesC. To remove the GST tag, 2.5 microg of GST-parkin was again bound to glutathione-Sepharose for 1 h at 4 degreesC in 1% Triton X-100/PBS (pH 7.4). The glutathione-Sepharose-bound GST-parkin was washed three times in 1% Triton X-100/PBS, and three times in cleavage buffer (in mm: Tris-HCl, 50, pH 7.0; NaCl, 150; EDTA, 1; dithiothreitol, 1). GST-parkin was then cleaved on the beads by incubation with 5 units PreScission Protease (Amersham) for 4 h at 5 degreesC. Effective removal of the GST moiety was confirmed by determination of the molecular mass of recombinant parkin using SDS-PAGE and Western blot (not shown).
###end p 19
###begin title 20
Statistics
###end title 20
###begin p 21
###xml 66 71 66 71 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">anova</sc>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical significance of differences was analysed with one-way anova and Student-Newman-Keuls test (SigmaStat 3.5, Systat). Differences were considered significant at P < 0.05. Values represent mean +/- SEM.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
###xml 0 70 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parkin is part of a stable, non-covalent, &#8764;110-kDa complex</italic>
Parkin is part of a stable, non-covalent, approximately110-kDa complex in vivo
###end title 23
###begin p 24
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 145 166 145 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">Sch&#228;gger <italic>et al.</italic>, 1994</xref>
###xml 181 187 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 168 194 168 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Vandenberghe <italic>et al.</italic>, 2005a</xref>
###xml 441 448 441 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 964 971 956 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 1246 1253 1238 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 1515 1522 1507 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 1626 1632 1618 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1619 1639 1611 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Pawlyk <italic>et al.</italic> (2003)</xref>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 1374 1378 <span type="species:ncbi:10090">mice</span>
In contrast to SDS-PAGE, BN-PAGE is performed in non-denaturing conditions and thus permits separation of intact non-covalent protein complexes (Schagger et al., 1994; Vandenberghe et al., 2005a). We used this technique to determine the native molecular mass of parkin extracted from the brain stem and diencephalon of 2- to 4-month-old mice. Brain homogenates were separated by centrifugation into pellet (P) and supernatant (S) fractions (Fig. 1A). Fraction P was enriched in membranes, as demonstrated by Western blotting for the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit glutamate receptor subunit 2 (GluR2), a neuronal membrane protein; fraction S was mostly cytosolic, as indicated by Western blotting for the cytoplasmic protein alpha-tubulin (data not shown). After incubation with 1% Triton X-100, solubilized proteins from fractions P and S were further fractionated by centrifugation on 10-50% glycerol gradients (Fig. 1A). The resulting fractions (P1-12 and S1-12) were subjected to BN-PAGE followed by immunoblotting with CS2132, a commonly used, commercially available polyclonal anti-parkin antibody. This antibody detected a band in fraction S6 with a very high molecular mass (450-550 kDa; Fig. 2A). To check the specificity of the CS2132 antibody, we performed parallel experiments on brain extracts from parkin-null mice. However, the 450-550-kDa complex was equally detected in parkin-null extracts, indicating that it was not an authentic parkin complex (Fig. 2A). The observed lack of specificity of the CS2132 antibody was in agreement with the findings of Pawlyk et al. (2003).
###end p 24
###begin p 25
###xml 285 292 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 1400 1406 <span type="species:ncbi:9913">bovine</span>
BN-PAGE reveals a stable, non-covalent, approximately110-kDa parkin complex in brain. (A and B) Extracts of brain stem and diencephalon from wild-type and parkin knockout (KO) mice were separated into pellet (P) and supernatant (S) fractions, as described in Materials and methods and Fig. 1A. P and S fractions were further fractionated by glycerol gradient centrifugation. Twelve P and 12 S fractions (numbered from the top of the glycerol gradient to the bottom) were analysed by BN-PAGE, followed by Western blotting with either the polyclonal anti-parkin antibody CS2132 (A) or the monoclonal anti-parkin antibody PRK109 (B) The CS2132 antibody detected a 450-550-kDa band in fraction S6, which was also found in parkin-null extract (A). By contrast, the PRK109 antibody (B) revealed a band in fraction S5 at a lower molecular weight (indicated by the arrow), which was absent in parkin knockout brain. The PRK109 antibody also showed some minor, non-specific immunoreactivity at higher molecular weights (indicated by the asterisk) in S5 from both wild-type and parkin knockout. (C) The graph shows how BN gels were calibrated based on the relative mobilities of native protein size markers to determine the molecular weight (MW) of the parkin complex. Markers, denoted by black circles, were thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), lactate dehydrogenase (140 kDa) and bovine serum albumin (67 kDa). The dotted line indicates the estimated MW of the parkin complex. (D) In the left and middle panels, heating brain fraction S5 at 100 degreesC in 1.5% sodium dodecyl sulphate (SDS) for 10 min immediately prior to BN-PAGE disrupted the approximately110-kDa parkin complex and led to the appearance of monomeric parkin (indicated by the arrow). In the rightmost panel, approximately 50 ng of purified recombinant parkin was analysed by BN-PAGE and Western blot with PRK109 without heat treatment or addition of SDS, revealing a band (indicated by the arrow) with apparent molecular weight (approximately50 kDa) consistent with that of monomeric parkin. (E) Omission of Triton X-100 from the extraction protocol did not change the native molecular mass of the parkin complex from brain or the amount of parkin extracted. Numbers to the left of (A), (B), (D) and (E) indicate MWs of the native protein size markers.
###end p 25
###begin p 26
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 131 150 131 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Pawlyk <italic>et al.</italic>, 2003</xref>
###xml 304 311 304 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
###xml 469 476 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2C</xref>
###xml 482 488 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 478 494 466 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Lee <italic>et al.</italic>, 2002</xref>
###xml 732 739 720 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
###xml 915 922 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
###xml 1036 1043 1012 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2D</xref>
###xml 1369 1376 1321 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2D</xref>
We therefore switched to using PRK8 and PRK109, two monoclonal antibodies that were previously demonstrated to be parkin specific (Pawlyk et al., 2003). These antibodies detected a single band concentrated in fraction S5, which represented authentic parkin because it was absent in parkin-null extracts (Fig. 2B). This native parkin band had an estimated molecular mass of approximately110 kDa, based on its mobility relative to native markers of known molecular mass (Fig. 2C; Lee et al., 2002). A small amount of parkin of similar molecular weight was detectable in fraction P5, but only after much more prolonged film exposure (data not shown). There was also some minor immunoreactivity at higher molecular weights (asterisk in Fig. 2B), but this was also found in the parkin knockout and thus probably resulted from non-specific binding. Remarkably, monomeric parkin was undetectable in native brain extracts (Fig. 2B). Importantly, purified recombinant parkin had an apparent molecular mass of approximately50 kDa on native gels (Fig. 2D), indicating that the approximately110-kDa parkin band represented a protein complex rather than an unusual tertiary conformation of the parkin monomer. Boiling brain extracts in 1.5% SDS for 10 min before BN-PAGE completely disassembled the approximately110-kDa parkin complex and led to the appearance of monomeric parkin (Fig. 2D), indicating that the parkin complex was held together by non-covalent interactions.
###end p 26
###begin p 27
###xml 28 35 28 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 36 37 36 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">C</xref>
###xml 388 395 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2E</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2E</xref>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 627 646 627 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Pawlyk <italic>et al.</italic>, 2003</xref>
###xml 529 534 <span type="species:ncbi:10090">mouse</span>
In the experiments shown in Fig. 2A-C brain extracts were solubilized in 1% Triton X-100. Although this is a mild detergent, we wondered whether any parkin interactions might still be disrupted. However, this was not the case, as shown by the fact that omission of Triton X-100 from the extraction protocol did not affect the apparent molecular mass of the parkin complex on native gels (Fig. 2E). Omission of Triton X-100 also did not diminish the amount of parkin extracted (Fig. 2E), consistent with the previous finding that mouse parkin is highly soluble and easily extracted from brain even in the absence of detergents (Pawlyk et al., 2003).
###end p 27
###begin p 28
###xml 262 268 250 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3</xref>
As an independent approach, we determined the molecular mass of native parkin by gel filtration chromatography of fraction S in the absence of detergents. Parkin eluted from the column as a single peak with an estimated molecular weight of approximately105 kDa (Fig. 3), consistent with the BN-PAGE results. Monomeric parkin was again undetectable.
###end p 28
###begin p 29
###xml 750 751 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 751 753 751 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">av</sub>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 758 759 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 762 763 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 763 764 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 768 769 768 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 772 773 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 773 774 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 783 784 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 784 785 784 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 804 805 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 805 806 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 825 826 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 826 827 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 522 528 <span type="species:ncbi:9913">bovine</span>
Demonstration of the parkin complex in brain by gel filtration chromatography. (A) Fraction S prepared in the absence of detergents was applied to a gel filtration column. Fractions of 0.5 mL were eluted from the column and fractions 11-70 were analysed with dot blot for parkin using the PRK109 antibody. Fraction numbers are indicated to the left of the blot. Molecular weights (MWs) indicate the elution patterns of the protein size markers thyroglobulin (669 kDa), ferritin (440 kDa), lactate dehydrogenase (140 kDa), bovine serum albumin (67 kDa), vitamin D-binding protein (55 kDa) and protein phosphatase 2A phosphatase activator (36 kDa). (B) Calibration graph of the gel filtration column. The black circles denote the protein size markers. Kav = (Ve - Vo)/(Vt - Vo), where Ve = elution volume, Vo = void volume and Vt = total column volume. The dotted line indicates the estimated MW of the parkin complex.
###end p 29
###begin p 30
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 112 131 112 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Kitada <italic>et al.</italic>, 1998</xref>
###xml 284 291 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 444 450 432 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
The parkin gene is not only expressed in brain but also in other tissues, especially heart and skeletal muscle (Kitada et al., 1998). To find out whether the components of the approximately110-kDa parkin complex were also expressed outside the brain, we applied the protocol shown in Fig. 1A to mouse heart and skeletal muscle. The apparent molecular mass of parkin on native gels was similar in extracts from heart, skeletal muscle and brain (Fig. 4), suggesting that none of the components of the parkin complex was brain specific.
###end p 30
###begin p 31
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
Formation of the approximately110-kDa parkin complex is conserved across tissues. S fractions were prepared from mouse heart, skeletal muscle and brain (Br.). The samples were analysed with glycerol gradient centrifugation, BN-PAGE and Western blotting with the monoclonal anti-parkin antibody PRK8. The arrow indicates the position of the approximately110-kDa parkin complex.
###end p 31
###begin p 32
Next we performed immunoprecipitation experiments on brain extracts using the parkin-specific monoclonal antibodies and separated the immunoprecipitates by SDS-PAGE, in order to identify the components of the parkin complex by silver staining of the gels and mass spectrometry. However, comparison of silver-stained gels of immunoprecipitates from wild-type and parkin-null brains failed to reveal any specific bands (data not shown). This was possibly due to low abundance of the parkin complex in brain, low affinity of the monoclonal parkin antibodies, or masking of specific bands on the gel by the light or heavy chain bands of the immunoprecipitating antibody.
###end p 32
###begin p 33
###xml 289 295 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 283 301 283 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Kalia <italic>et al.</italic>, 2004</xref>
###xml 315 321 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 310 327 310 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Imai <italic>et al.</italic>, 2002</xref>
###xml 346 352 344 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 341 358 339 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Sato <italic>et al.</italic>, 2006</xref>
###xml 380 386 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 370 392 368 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Staropoli <italic>et al.</italic>, 2003</xref>
###xml 410 416 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 405 422 403 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Imai <italic>et al.</italic>, 2002</xref>
###xml 522 528 520 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5</xref>
###xml 602 608 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 597 614 588 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Yang <italic>et al.</italic>, 2005</xref>
###xml 737 744 716 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6A</xref>
###xml 1141 1148 1113 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6B</xref>
###xml 1363 1369 1335 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1358 1375 1330 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">Yang <italic>et al.</italic>, 2002</xref>
###xml 1390 1396 1362 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1377 1403 1349 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Vandenberghe <italic>et al.</italic>, 2005a</xref>
###xml 1522 1529 1494 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6B</xref>
###xml 1661 1668 1633 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6C</xref>
###xml 1743 1749 1715 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1736 1755 1708 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Fallon <italic>et al.</italic>, 2002</xref>
###xml 2055 2061 2015 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2048 2067 2008 2027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Sakata <italic>et al.</italic>, 2003</xref>
###xml 2085 2091 2045 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2077 2097 2037 2057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Dachsel <italic>et al.</italic>, 2005</xref>
###xml 2112 2118 2072 2078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2107 2124 2067 2084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Imai <italic>et al.</italic>, 2000</xref>
###xml 2134 2140 2094 2100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2126 2146 2086 2106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Shimura <italic>et al.</italic>, 2001</xref>
###xml 2169 2175 2129 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2159 2181 2119 2141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Staropoli <italic>et al.</italic>, 2003</xref>
###xml 2197 2203 2157 2163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2190 2209 2150 2169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Baulac <italic>et al.</italic>, 2004</xref>
###xml 2231 2237 2191 2197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2225 2243 2185 2203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Chung <italic>et al.</italic>, 2001</xref>
###xml 2262 2268 2222 2228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2256 2274 2216 2234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Zhang <italic>et al.</italic>, 2000</xref>
###xml 2302 2308 2258 2264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2294 2314 2250 2270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Shimura <italic>et al.</italic>, 2001</xref>
###xml 2328 2334 2284 2290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2322 2340 2278 2296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Corti <italic>et al.</italic>, 2003</xref>
###xml 2368 2374 2320 2326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2363 2380 2315 2332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Henn <italic>et al.</italic>, 2007</xref>
###xml 2583 2589 2535 2541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2577 2595 2529 2547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Smith <italic>et al.</italic>, 2005</xref>
###xml 2609 2615 2561 2567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2606 2621 2558 2573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Um <italic>et al.</italic>, 2006</xref>
###xml 2638 2644 2590 2596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2631 2650 2583 2602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Fallon <italic>et al.</italic>, 2006</xref>
###xml 2672 2678 2624 2630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2666 2684 2618 2636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">Huynh <italic>et al.</italic>, 2007</xref>
As an alternative approach for identification of the components of the native parkin complex, we compared the migration of parkin in glycerol gradients and native gels with that of previously published parkin-binding partners. However, the reported parkin-interacting proteins BAG5 (Kalia et al., 2004), CHIP (Imai et al., 2002), 14-3-3eta (Sato et al., 2006), hSel-10 (Staropoli et al., 2003) and Hsp70 (Imai et al., 2002) migrated in characteristic, reproducible band patterns that clearly differed from that of parkin (Fig. 5). By contrast, immunoreactivity for alpha-tubulin and beta-tubulin (Yang et al., 2005), two proteins with monomeric molecular masses of approximately50 kDa, partially overlapped with the 110-kDa parkin band (Fig. 6A). One possible interpretation was that the parkin band represented a stable complex of parkin with monomeric tubulin. Alternatively, the overlap of immunoreactivity could simply be due to the close proximity of the molecular weight of the alpha/beta-tubulin heterodimer to that of the parkin complex. To discriminate between these two possibilities, we performed antibody supershift experiments (Fig. 6B). If parkin and tubulin coexist in a stable complex, incubation of extracts with anti-tubulin antibody before BN-PAGE should change the migration of parkin due to antibody binding to parkin-tubulin complexes (Yang et al., 2002; Vandenberghe et al., 2005a). However, this was not the case, arguing against the existence of a stable parkin-tubulin complex in these extracts (Fig. 6B). This conclusion was further supported by the similar migration pattern of tubulin from wild-type and parkin-null brain extracts (Fig. 6C). Not unexpectedly, immunoreactivity for the 104-kDa protein CASK (Fallon et al., 2002) also partially overlapped with the approximately110-kDa parkin band, but antibody supershift experiments and comparison with parkin-null extracts did not show evidence for the presence of a stable parkin-CASK complex (data not shown). Other published parkin-binding proteins, such as Rpn10 (Sakata et al., 2003), XAPC7 (Dachsel et al., 2005), UbcH7 (Imai et al., 2000; Shimura et al., 2001), cullin-1 (Staropoli et al., 2003), DJ-1 (Baulac et al., 2004), synphilin-1 (Chung et al., 2001), CDCrel-1 (Zhang et al., 2000), alpha-synuclein (Shimura et al., 2001), p38 (Corti et al., 2003), TRAF2 and IKKgamma (Henn et al., 2007), equally failed to show detectable association with the parkin complex on native gels (data not shown). We did not check the migration patterns of the recently reported parkin interactors LRRK2 (Smith et al., 2005), RANBP2 (Um et al., 2006), Eps15 (Fallon et al., 2006) and ataxin-2 (Huynh et al., 2007), because these proteins, with predicted molecular weights of approximately285 kDa, approximately385 kDa, approximately142 kDa and approximately136 kDa, respectively, were too large to be subunits of the approximately110-kDa parkin complex.
###end p 33
###begin p 34
###xml 263 271 <span type="species:ncbi:301928">ellipses</span>
Known parkin-interacting proteins do not show detectable association with parkin on native gels. (A-F) S and P fractions from brain were separated by glycerol gradient centrifugation and BN-PAGE, followed by Western blotting for the protein indicated. The dotted ellipses indicate the position of the parkin band, as determined by reprobing each blot with anti-parkin.
###end p 34
###begin p 35
###xml 269 277 <span type="species:ncbi:301928">ellipses</span>
###xml 596 602 <span type="species:ncbi:9986">rabbit</span>
###xml 608 614 <span type="species:ncbi:9986">rabbit</span>
###xml 717 722 <span type="species:ncbi:10090">mouse</span>
###xml 796 801 <span type="species:ncbi:10090">mouse</span>
Lack of a detectable stable complex of parkin with tubulin. (A) Fraction S from brain was separated by glycerol gradient centrifugation, and fractions S4-S6 were analysed by BN-PAGE and Western blotting for parkin, alpha-tubulin or beta-tubulin (beta-Tub.). The dotted ellipses indicate the position of the parkin band, as determined by reprobing each blot with anti-parkin. In the rightmost panel, fraction S was boiled in 1.5% sodium dodecyl sulphate (SDS) for 10 min before BN-PAGE to identify the monomeric tubulin band. (B) Fractions S4-S6 were incubated for 90 min with 5 microg of control rabbit IgG, rabbit anti-alpha-tubulin (Tub. Ab), or buffer alone (Tris) before BN-PAGE. After Western blotting (WB) with mouse anti-alpha-tubulin (left panel), the blot was stripped and reprobed with mouse anti-parkin (right panel). Pre-incubation with polyclonal anti-alpha-tubulin fully shifted the alpha-tubulin bands to higher molecular weights due to antibody binding and cross-linking of tubulin complexes (left panel), but did not shift the parkin band (right panel). (C) The migration pattern of native beta-tubulin from parkin knockout (KO) brain is similar to that in the wild-type extracts shown in (A).
###end p 35
###begin title 36
The approximately110-kDa parkin complex is not a parkin homodimer
###end title 36
###begin p 37
###xml 260 267 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2D</xref>
###xml 452 458 428 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7</xref>
###xml 774 783 738 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7A&#8211;C</xref>
###xml 1146 1153 1086 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7D</xref>
We considered the possibility that the approximately110-kDa parkin complex might be a parkin homodimer. However, this was highly unlikely for four reasons. First, the apparent molecular mass (approximately50 kDa) of purified recombinant parkin on native gels (Fig. 2D) already suggested that parkin does not easily form homodimers. Second, parkin overexpression experiments in cell lines argued against a homodimeric composition of the parkin complex (Fig. 7). Endogenous parkin was not detectable with our BN-PAGE assay in untransfected COS1, SH-SY5Y, CHO or HEK-293 cells (data not shown). However, when we transfected parkin in COS1, SH-SY5Y or CHO cells, the protein accumulated predominantly as a monomer, with only minor formation of the approximately110-kDa complex (Fig. 7A-C). This strongly suggested that the approximately110-kDa complex was not a parkin dimer, but rather contained components that were present in limiting amounts in transfected COS1, SH-SY5Y and CHO cells. Interestingly, the abundance of the approximately110-kDa complex (relative to that of the parkin monomer) was dramatically higher in transfected HEK-293 cells (Fig. 7D) than in COS1, SH-SY5Y or CHO cells, suggesting that HEK-293 cells expressed higher endogenous levels of the binding partners required for complex formation.
###end p 37
###begin p 38
###xml 1287 1288 1263 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1670 1671 1642 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1959 1960 1919 1920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2094 2095 2054 2055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Overexpressed parkin accumulates predominantly as a monomer in several cell lines. (A) COS1 cells were transiently transfected with parkin and extracted in 1% Triton X-100, followed by glycerol gradient centrifugation of the extract. Glycerol gradient fractions 2-11 were analysed by BN-PAGE and immunoblotting for parkin. Upon overexpression parkin migrated as a monomer (indicated by the arrow on the left of the first panel). After more prolonged film exposure, a small amount of the approximately110-kDa complex was detected, as illustrated by comparison with the endogenous parkin band (indicated by the arrowhead) from brain (Br.). (B-D) SH-SY5Y (B), CHO (C) and HEK-293 (D) cells were transiently transfected with parkin and extracted in 1% Triton X-100. Glycerol gradient fractions 2-6 were analysed by BN-PAGE and immunoblotting for parkin. (B) The results of both brief and more prolonged film exposure are shown. In the rightmost panel of (B), total Triton-soluble extract from transfected SH-SY5Y cells was boiled in 1.5% SDS for 10 min immediately before BN-PAGE to identify the monomeric parkin band. The arrows and arrowheads indicate monomeric parkin and the approximately110-kDa parkin complex, respectively. (E) Either 30 or 250 ng of parkin cDNA was transfected per cm2 of COS1 cell culture. For each transfection condition, 20 microg of total protein extract was examined by sodium dodecyl sulphate (SDS)-PAGE and Western blotting, showing different total parkin expression levels. The mobility of a 50-kDa molecular weight marker is shown on the left of the blot. (F) Extracts of COS1 cells transfected with either 30 or 250 ng of parkin cDNA per cm2 were analysed by glycerol gradient centrifugation, and fractions 3-5 were subjected to BN-PAGE and parkin immunoblotting to visualize monomer (arrow) and approximately110-kDa complex (arrowhead). In the right panel, total Triton-soluble extract from COS1 cells transfected with 250 ng/cm2 of parkin cDNA was boiled in 1.5% SDS for 10 min immediately before BN-PAGE to identify the monomeric parkin band. When only 10 ng/cm2 of parkin cDNA was transfected, the protein was not detectable with the glycerol gradient centrifugation and BN-PAGE assay (not shown).
###end p 38
###begin p 39
###xml 70 83 70 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7E and F</xref>
Third, we also varied the transfection level of parkin in COS1 cells (Fig. 7E and F). With higher total parkin expression levels, there was relatively little change in the amount of complex, but there was a clear increase in the amount of monomer. Thus, formation of the approximately110-kDa complex again appeared to be limited by the endogenous levels of the required parkin-binding partners.
###end p 39
###begin p 40
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig08">Fig. 8A</xref>
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig08">Fig. 8B</xref>
###xml 227 234 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2D</xref>
###xml 1187 1193 1091 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig08">Fig. 8</xref>
Finally, partial denaturation experiments did not support a (homo)dimeric structure of the parkin complex. Heating extracts from brain (Fig. 8A) or transfected COS1 cells (Fig. 8B) to 65 degreesC (instead of 100 degreesC as in Fig. 2D) in 1.5% SDS led to partial dissociation of the parkin complex and the appearance of three parkin bands with estimated molecular masses of approximately 80, 60 and 50 kDa. The most parsimonious explanation for this observation would be that the approximately60-kDa band represented a complex of parkin with a protein other than parkin itself, the approximately80-kDa band reflected the association of a third component and the approximately110-kDa band arose from the addition of yet another subunit. According to this simple model, the approximately110-kDa complex would be a tetramer. Alternatively, it was also possible that, for example, the approximately60-kDa band represented a complex of parkin with more than one other protein, in which case the approximately110-kDa complex would contain more than four components. Hence, the findings suggested that the approximately110-kDa complex was at least a tetramer. In any case, the results shown in Fig. 8 were not consistent with the approximately110-kDa complex being a parkin homodimer.
###end p 40
###begin p 41
Partial dissociation of the parkin complex. (A) Heating fraction S from brain to 65 degreesC for 10 min in 1.5% sodium dodecyl sulphate (SDS) before BN-PAGE led to the appearance of three parkin bands (indicated by the arrows), suggesting that the approximately110-kDa complex was at least a tetramer. In the rightmost panel, fraction S was heated to 100 degreesC in 1.5% SDS for 10 min before BN-PAGE to dissociate the parkin complex completely and identify the position of the monomeric parkin band. (B) COS1 cells were transiently transfected with parkin and extracted in 1% Triton X-100. The cell extracts were treated in the same way as the brain extracts in (A).
###end p 41
###begin title 42
PD-linked parkin mutations compromise parkin complex formation
###end title 42
###begin p 43
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 146 163 146 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Henn <italic>et al.</italic>, 2005</xref>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 165 184 165 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Sriram <italic>et al.</italic>, 2005</xref>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 455 473 455 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
###xml 962 975 950 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig09">Fig. 9C and D</xref>
###xml 1201 1214 1177 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig09">Fig. 9A and B</xref>
###xml 1442 1449 1370 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig09">Fig. 9B</xref>
###xml 1504 1517 1432 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig09">Fig. 9C and D</xref>
###xml 1836 1842 1752 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1830 1848 1746 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
###xml 1942 1955 1858 1871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig09">Fig. 9C and D</xref>
###xml 2040 2047 1956 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig09">Fig. 9A</xref>
Many pathogenic parkin mutations have been shown to cause a loss of parkin function by impairing its solubility, stability or catalytic activity (Henn et al., 2005; Sriram et al., 2005). However, a subset of PD-linked parkin mutations (including the A82E, K161N, K211N and R256C missense mutations) have little impact on parkin solubility, stability or interaction with known binding partners or on its intrinsic catalytic activity in a cell-free system (Hampe et al., 2006). The pathogenic mechanism of these mutations thus remains elusive. We therefore explored whether the A82E, K161N, K211N and R256C mutations disrupted the approximately110-kDa complex. We transfected wild-type, A82E, K161N, K211N and R256C parkin cDNA into COS1 cells to determine the relative amounts of parkin complex and monomer. Importantly, Triton-soluble parkin levels were similar for the wild-type, A82E, K161N, K211N and R256C variants, as shown by parallel control experiments (Fig. 9C and D), thus precluding confounding effects of parkin expression levels on the observed complex/monomer ratios. Interestingly, each of the four mutations significantly impaired formation of the approximately110-kDa parkin complex (Fig. 9A and B). Quantitatively, the A82E, K161N, K211N and R256C mutations caused a approximately40%, approximately60%, approximately50% and approximately30% reduction, respectively, of the amount of parkin complex relative to total parkin (Fig. 9B). Given the similar soluble parkin expression levels (Fig. 9C and D), the differences in parkin complex/monomer ratio between wild-type and mutant proteins indicated a reduced intrinsic ability of the mutants to form the approximately110-kDa complex. We also examined the R275W parkin variant, which was previously shown to have reduced, but non-zero, solubility in Triton X-100 (Hampe et al., 2006). The Triton-soluble level of R275W parkin was indeed lower than that of the other variants (Fig. 9C and D). A small amount of R275W parkin monomer was detected, but no complex was observed (Fig. 9A).
###end p 43
###begin p 44
###xml 167 168 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 212 213 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 252 253 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 281 282 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 841 842 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1313 1319 1285 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1308 1325 1280 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Henn <italic>et al.</italic>, 2005</xref>
###xml 1785 1786 1757 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1805 1810 1777 1782 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">anova</sc>
Comparison of approximately110-kDa complex formation between wild-type (WT) parkin and PD-linked parkin variants. COS1 cells were transiently transfected with 70 ng/cm2 of WT or R256C mutant parkin cDNA, 50 ng/cm2 of A82E or K161N parkin cDNA, 30 ng/cm2 of K211N cDNA and 120 ng/cm2 of R275W cDNA. (A) Transfected COS1 cells were extracted in 1% Triton X-100, followed by glycerol gradient centrifugation of the extracts. Fractions 2-6 of the gradient were analysed by BN-PAGE and parkin immunoblotting to visualize monomer (arrowhead) and approximately110-kDa complex (arrow). (B) In the experiments shown in (A), the amounts of parkin complex and parkin monomer were quantified. The graph represents the amount of parkin complex, expressed as a percentage of the sum of parkin complex and monomer. Asterisks denote significant difference (P < 0.05) from WT. (C and D) In parallel with each of the experiments shown in (A and B), 15 microg of Triton-soluble protein extract was analysed with SDS-PAGE and parkin immunoblotting to compare soluble parkin protein levels between WT and mutant variants. At the low signal intensity of the blots shown in (C), parkin appeared as a doublet due to the presence of an N-terminally truncated parkin species generated through an internal translation initiation site (Henn et al., 2005). No endogenous parkin signal could be observed by SDS-PAGE in untransfected (Untransf.) COS1 cells (C), except after very prolonged film exposures (not shown). The graph in (D) shows SDS-PAGE and Western blot quantification of the Triton-soluble parkin levels. Within each experiment, the level of the parkin mutants was normalized to that of WT parkin. There were no significant differences in soluble parkin levels between WT, A82E, K161N, K211N or R256C (P = 0.96 by one-way anova).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parkin</italic>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 100 120 100 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">L&#252;cking <italic>et al.</italic>, 2000</xref>
###xml 200 206 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 195 212 195 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Imai <italic>et al.</italic>, 2000</xref>
###xml 222 228 222 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 214 234 214 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Shimura <italic>et al.</italic>, 2000</xref>
###xml 242 248 242 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 236 254 236 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Zhang <italic>et al.</italic>, 2000</xref>
###xml 672 679 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
Mutations in the parkin gene are the most common known cause of autosomal recessive early onset PD (Lucking et al., 2000). Seminal work has identified an E3 ubiquitin ligase function for parkin (Imai et al., 2000; Shimura et al., 2000; Zhang et al., 2000). However, it is unclear whether parkin is a monomer or functions in a larger protein complex. To address this issue, we have investigated parkin under native conditions. Our study has led to two important conclusions. First, parkin exists in mouse brain and muscle as part of a stable, non-covalent, heteromeric complex with a molecular mass of approximately110 kDa. Surprisingly, monomeric parkin is not detectable in vivo. Second, PD-linked parkin mutations significantly compromise formation of this complex.
###end p 46
###begin p 47
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 85 104 85 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Pawlyk <italic>et al.</italic>, 2003</xref>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 163 186 163 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Winklhofer <italic>et al.</italic>, 2003</xref>
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 188 207 188 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">LaVoie <italic>et al.</italic>, 2005</xref>
###xml 214 220 214 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 209 226 209 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Wang <italic>et al.</italic>, 2005</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
Recent work has shown that the solubility of parkin decreases in ageing human brain (Pawlyk et al., 2003) and that oxidative stress can induce parkin aggregation (Winklhofer et al., 2003; LaVoie et al., 2005; Wang et al., 2005). However, the approximately110-kDa parkin complex detected in this study is clearly not an aggregate, for three reasons. First, a parkin aggregate would be expected to be poorly soluble and to be extractable only in harsher detergents, whereas the approximately110-kDa parkin complex is highly soluble and easily extracted from mouse brain even in the absence of detergents. Second, aggregated parkin would be expected to appear on the gel as a ladder or smear of high-molecular-weight species rather than as a discrete band of approximately110 kDa. Third, conditions of transient overexpression generally increase the tendency of proteins to aggregate due to molecular crowding. However, upon overexpression in COS1, SH-SY5Y or CHO cells parkin accumulated in monomeric form with only limited formation of the approximately110-kDa parkin complex. This led to the conclusion that the approximately110-kDa complex was not an aggregate, but rather a complex of parkin with other proteins that were available in limiting amounts in the transfected cells.
###end p 47
###begin p 48
In the present study previously reported parkin-interacting proteins did not show detectable association with the parkin complex after glycerol velocity gradient centrifugation and BN-PAGE. However, this assay is primarily designed to demonstrate interactions between stoichiometric components of stable protein complexes. The assay is less appropriate for detection of transient interactions (e.g. enzyme-substrate interactions) or of stable interactions that involve only a small percentage of the parkin molecules. Also, some parkin interactions may be weak and may therefore be disrupted during the prolonged centrifugation and electrophoresis procedures. Therefore, the lack of observable co-migration of the parkin complex and known parkin-binding proteins does not argue against the authenticity of the previously reported parkin interactions, and the present study by no means implies that parkin does not bind to its published partners. Nevertheless, our findings raise the tantalizing possibility that some of the most stable binding partners of parkin still remain to be identified.
###end p 48
###begin p 49
###xml 918 924 894 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 912 930 888 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
###xml 1083 1089 1059 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1077 1095 1053 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Chung <italic>et al.</italic>, 2001</xref>
###xml 1104 1110 1080 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1097 1116 1073 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Sriram <italic>et al.</italic>, 2005</xref>
###xml 1206 1212 1182 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1200 1218 1176 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
It is tempting to speculate that the as yet unidentified constituents of the approximately110-kDa complex may be required for optimal parkin function. For example, the other subunits could control parkin stability, subcellular localization, substrate specificity or ubiquitin ligase activity (including the preference of parkin for mono- vs polyubiquitination). If so, genes encoding the other components of the complex would be attractive candidates for inherited forms of parkinsonism and other neurodegenerative syndromes. Intriguingly, we observed that the PD-linked parkin mutants A82E, K161N, K211N and R256C have a significantly reduced ability to form the approximately110-kDa complex. If complex formation is indeed necessary for proper functioning of parkin in cells, the observed reduced capacity for complex formation will explain the hitherto poorly understood pathogenic nature of these mutations (Hampe et al., 2006). Also, this would resolve the paradox that the K161N and R256C mutants have less ubiquitination activity than wild-type when expressed in cells (Chung et al., 2001; Sriram et al., 2005), while possessing normal intrinsic ubiquitination activity in a cell-free system (Hampe et al., 2006).
###end p 49
###begin p 50
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 338 361 338 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Winklhofer <italic>et al.</italic>, 2003</xref>
###xml 368 374 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 363 380 363 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Henn <italic>et al.</italic>, 2005</xref>
###xml 389 395 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 382 401 382 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Sriram <italic>et al.</italic>, 2005</xref>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 403 421 403 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Hampe <italic>et al.</italic>, 2006</xref>
###xml 520 526 520 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 509 532 509 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Winklhofer <italic>et al.</italic>, 2003</xref>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 534 553 534 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">LaVoie <italic>et al.</italic>, 2005</xref>
###xml 560 566 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 555 572 555 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Wang <italic>et al.</italic>, 2005</xref>
###xml 600 606 600 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 593 612 593 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Pawlyk <italic>et al.</italic>, 2003</xref>
Interestingly, the absence of detectable monomeric parkin in brain and muscle suggests that endogenous expression levels of parkin are limiting for formation of this complex in vivo. This would make this complex exquisitely vulnerable to even slight reductions in the availability of soluble parkin that may result from parkin mutations (Winklhofer et al., 2003; Henn et al., 2005; Sriram et al., 2005; Hampe et al., 2006), as illustrated by our experiments with the R275W mutant. Cellular stress conditions (Winklhofer et al., 2003; LaVoie et al., 2005; Wang et al., 2005) and normal ageing (Pawlyk et al., 2003) are also known to impair parkin solubility and would therefore also be predicted to reduce the level of the parkin complex.
###end p 50
###begin p 51
###xml 576 582 576 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 569 588 569 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Capell <italic>et al.</italic>, 1998</xref>
###xml 854 871 850 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">De Strooper, 2003</xref>
Further biochemical purification of the native parkin complex will be required to elucidate the identity of its components and to determine how they control parkin function. An analogy can be made with the identification of the subunits of the Alzheimer's disease-linked presenilin complex. One of the first indications that the presenilins functioned as part of a stable, oligomeric protein complex was that glycerol velocity gradient centrifugation suggested a much higher native molecular weight for the presenilins than expected based on their amino acid sequence (Capell et al., 1998). It has taken several years and a variety of experimental approaches from multiple laboratories to identify nicastrin, anterior pharynx defective-1 (Aph-1) and presenilin enhancer-2 (Pen-2) as the additional constituents of the functional gamma-secretase complex (De Strooper, 2003).
###end p 51
###begin p 52
We are grateful to Dr V. Lee (University of Pennsylvania) for the gift of monoclonal parkin antibodies, to Dr K. Winklhofer (Max-Planck-Institute for Biochemistry, Martinsried, Germany) for parkin cDNA and to Dr S. Kim (Seoul National University) for the p38 antibody. We thank K. Schildermans for technical assistance with gel filtration chromatography and J. Krishnan for advice on SH-SY5Y transfection. W.V. is a Senior Clinical Investigator of the Fund for Scientific Research - Flanders (FWO), and this work was supported by Research Grants from the FWO and the University of Leuven. A.B. is supported by Fondation de France and APOPIS (EC contract no. LSHM-CT2003-503330).
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
###xml 101 106 <span type="species:ncbi:9606">human</span>
Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain
###end article-title 54
###begin article-title 55
The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex
###end article-title 55
###begin article-title 56
Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease
###end article-title 56
###begin article-title 57
The p38 subunit of the aminoacyl-tRNA synthetase complex is a parkin substrate: linking protein biosynthesis and neurodegeneration
###end article-title 57
###begin article-title 58
Parkin interacts with the proteasome subunit alpha4
###end article-title 58
###begin article-title 59
Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex
###end article-title 59
###begin article-title 60
A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3) K-Akt signalling
###end article-title 60
###begin article-title 61
Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain
###end article-title 61
###begin article-title 62
Biochemical analysis of Parkinson's disease-causing variants of parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity
###end article-title 62
###begin article-title 63
Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling
###end article-title 63
###begin article-title 64
Pathogenic mutations inactivate parkin by distinct mechanisms
###end article-title 64
###begin article-title 65
Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death
###end article-title 65
###begin article-title 66
CHIP is associated with parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity
###end article-title 66
###begin article-title 67
An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin
###end article-title 67
###begin article-title 68
Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity
###end article-title 68
###begin article-title 69
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse
###end article-title 69
###begin article-title 70
BAG5 inhibits parkin and enhances dopaminergic neuron degeneration
###end article-title 70
###begin article-title 71
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
###end article-title 71
###begin article-title 72
Dopamine covalently modifies and functionally inactivates parkin
###end article-title 72
###begin article-title 73
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 93 98 <span type="species:ncbi:4932">yeast</span>
Ceramide biosynthesis is required for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic reticulum
###end article-title 73
###begin article-title 74
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation
###end article-title 74
###begin article-title 75
French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. Association between early-onset Parkinson's disease and mutations in the parkin gene
###end article-title 75
###begin article-title 76
Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age
###end article-title 76
###begin article-title 77
Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation
###end article-title 77
###begin article-title 78
Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain
###end article-title 78
###begin article-title 79
14-3-3eta is a novel regulator of parkin ubiquitin ligase
###end article-title 79
###begin article-title 80
Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis
###end article-title 80
###begin article-title 81
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
###end article-title 81
###begin article-title 82
###xml 63 68 <span type="species:ncbi:9606">human</span>
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease
###end article-title 82
###begin article-title 83
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
###end article-title 83
###begin article-title 84
Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin
###end article-title 84
###begin article-title 85
Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity
###end article-title 85
###begin article-title 86
Parkin ubiquitinates and promotes the degradation of RanBP2
###end article-title 86
###begin article-title 87
Stargazin is an AMPA receptor auxiliary subunit
###end article-title 87
###begin article-title 88
Interaction with the unfolded protein response reveals a role for stargazin in biosynthetic AMPA receptor transport
###end article-title 88
###begin article-title 89
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function
###end article-title 89
###begin article-title 90
Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones
###end article-title 90
###begin article-title 91
Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER
###end article-title 91
###begin article-title 92
Parkin stabilizes microtubules through strong binding mediated by three independent domains
###end article-title 92
###begin article-title 93
Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
###end article-title 93
###begin title 94
Abbreviations
###end title 94
###begin p 95
bcl-2-associated athanogene 5
###end p 95
###begin p 96
blue native-polyacrylamide gel electrophoresis
###end p 96
###begin p 97
calcium/calmodulin-dependent serine protein kinase
###end p 97
###begin p 98
cell division control-related protein 1
###end p 98
###begin p 99
C-terminus of Hsp70-interacting protein
###end p 99
###begin p 100
Dulbecco's modified Eagle medium
###end p 100
###begin p 101
epidermal-growth-factor receptor pathway substrate clone 15
###end p 101
###begin p 102
heat shock protein 70
###end p 102
###begin p 103
IkappaB kinase gamma
###end p 103
###begin p 104
leucine-rich repeat kinase 2
###end p 104
###begin p 105
pellet
###end p 105
###begin p 106
phosphate buffered saline
###end p 106
###begin p 107
Parkinson's disease
###end p 107
###begin p 108
Ras-related nuclear small G-protein-binding protein 2
###end p 108
###begin p 109
regulatory particle non-ATPase 10
###end p 109
###begin p 110
supernatant
###end p 110
###begin p 111
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
###end p 111
###begin p 112
tumour necrosis factor receptor-associated factor 2
###end p 112
###begin p 113
###xml 22 27 <span type="species:ncbi:9606">human</span>
ubiquitin-conjugating human enzyme 7.
###end p 113

